Trials / Conditions / Parkinson's Disease Dementia

Parkinson's Disease Dementia

11 registered clinical trials studyying Parkinson's Disease Dementia — 1 currently recruiting.

Status	Trial	Sponsor	Phase
Active Not Recruiting	To Assess the Efficacy and Safety of Ceftriaxone in Patients With Mild to Moderate Parkinson's Disease Dementi NCT03413384	BrainX Corporation	Phase 2
Terminated	Open-label Study of Nelotanserin in Lewy Body Dementia With Visual Hallucinations or REM Sleep Behavior Disord NCT02871427	Axovant Sciences Ltd.	Phase 2
Completed	Study Evaluating Intepirdine (RVT-101) on Gait and Balance in Subjects With Dementia NCT02910102	Axovant Sciences Ltd.	Phase 2
Completed	Study Evaluating Nelotanserin for Treatment of REM Sleep Behavior Disorder in Subjects With Dementia (DLB or P NCT02708186	Axovant Sciences Ltd.	Phase 2
Completed	Imaging Inflammation in Patients With Parkinson's Disease Dementia or Dementia With Lewy Bodies NCT02702102	Columbia University	Phase 2
Unknown	Ambroxol as a Treatment for Parkinson's Disease Dementia NCT02914366	London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's	Phase 2
Completed	Nilotinib in Cognitively Impaired Parkinson Disease Patients 001 NCT02281474	Georgetown University	Phase 1
Completed	An Observational Study for the Prevalence of Neuropsychiatric Symptom in Parkinson's Disease Dementia NCT01102582	The Catholic University of Korea	—
Recruiting	Cerebro Spinal Fluid Collection (CSF) NCT04844060	University Hospital, Strasbourg, France	—
Completed	Long-term Safety of Rivastigmine Capsule and Patch in Patients With Mild to Moderately-severe Dementia Associa NCT00623103	Novartis	Phase 3
Completed	Memantine Versus Placebo in Parkinson's Disease Dementia or Dementia With Lewy Bodies NCT00855686	H. Lundbeck A/S	Phase 4